Intrapulmonic Cavity or Necrosis on Baseline CT Scan Serves as an Efficacy Predictor of Anti-PD-(L)1 Inhibitor in Advanced Lung Squamous Cell Carcinoma.
Tao LuLongfeng ZhangMingqiu ChenXiaobin ZhengKan JiangXinlong ZhengChao LiWeijin XiaoQian MiaoShanshan YangGen LinPublished in: Cancer management and research (2021)
LSCC patients with intrapulmonic cavity or necrosis on baseline CT scan may respond poorly to anti-PD-(L)1-treatment, monotherapy and combination therapy alike.